These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22265064)

  • 1. Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand.
    Prukkanone B; Vos T; Bertram M; Lim S
    Value Health; 2012; 15(1 Suppl):S3-8. PubMed ID: 22265064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of major depression avoidable by longer-term treatment strategies.
    Vos T; Haby MM; Barendregt JJ; Kruijshaar M; Corry J; Andrews G
    Arch Gen Psychiatry; 2004 Nov; 61(11):1097-103. PubMed ID: 15520357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of cognitive behavioral therapy for bulimia nervosa in the Australian context.
    Le LK; Hay P; Wade T; Touyz S; Mihalopoulos C
    Int J Eat Disord; 2017 Dec; 50(12):1367-1377. PubMed ID: 29044626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK.
    Koeser L; Donisi V; Goldberg DP; McCrone P
    Psychol Med; 2015 Oct; 45(14):3019-31. PubMed ID: 26040631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (Prozac) in treating depression: a randomized clinical trial.
    Sava FA; Yates BT; Lupu V; Szentagotai A; David D
    J Clin Psychol; 2009 Jan; 65(1):36-52. PubMed ID: 19051275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
    Revicki DA; Brown RE; Keller MB; Gonzales J; Culpepper L; Hales RE
    J Clin Psychiatry; 1997 Feb; 58(2):47-58. PubMed ID: 9062373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
    Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
    Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
    Domino ME; Foster EM; Vitiello B; Kratochvil CJ; Burns BJ; Silva SG; Reinecke MA; March JS
    J Am Acad Child Adolesc Psychiatry; 2009 Jul; 48(7):711-720. PubMed ID: 19465880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
    Serfaty MA; Haworth D; Blanchard M; Buszewicz M; Murad S; King M
    Arch Gen Psychiatry; 2009 Dec; 66(12):1332-40. PubMed ID: 19996038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of interventions for reducing road traffic injuries related to driving under the influence of alcohol.
    Ditsuwan V; Lennert Veerman J; Bertram M; Vos T
    Value Health; 2013; 16(1):23-30. PubMed ID: 23337212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthopaedic trauma care in Haiti: a cost-effectiveness analysis of an innovative surgical residency program.
    Carlson LC; Slobogean GP; Pollak AN
    Value Health; 2012; 15(6):887-93. PubMed ID: 22999139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
    Leelahanaj T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Anton SF; Revicki DA
    Psychopharmacol Bull; 1995; 31(2):249-58. PubMed ID: 7491376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.